The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-17
DOI
10.1038/s41388-019-0684-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory T cells: a potential target in cancer immunotherapy
- (2018) Kohei Shitara et al. Annals of the New York Academy of Sciences
- The P2X7 receptor: A main player in inflammation
- (2018) Elena Adinolfi et al. BIOCHEMICAL PHARMACOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction
- (2018) Robert Furler et al. Cancers
- The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells
- (2018) Henrique Borges da Silva et al. NATURE
- The P2X7 Receptor in Infection and Inflammation
- (2017) Francesco Di Virgilio et al. IMMUNITY
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Extracellular nucleosides and nucleotides as immunomodulators
- (2017) Oliver Kepp et al. IMMUNOLOGICAL REVIEWS
- Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection
- (2017) Joaquín Amores-Iniesta et al. Cell Reports
- ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
- (2017) Mariangela Lecciso et al. Frontiers in Immunology
- Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- (2016) Federico Pietrocola et al. CANCER CELL
- Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
- (2016) Andrea Giannuzzo et al. INTERNATIONAL JOURNAL OF CANCER
- P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction
- (2016) Luiz Eduardo Baggio Savio et al. MOLECULAR NEUROBIOLOGY
- Extracellular purines, purinergic receptors and tumor growth
- (2016) F Di Virgilio et al. ONCOGENE
- P2X7 targeting inhibits growth of human mesothelioma
- (2016) Francesca Amoroso et al. Oncotarget
- Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
- (2016) Erica Salaro et al. Scientific Reports
- Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer
- (2015) P. Hofman et al. CANCER RESEARCH
- Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock
- (2015) Dahai Yang et al. IMMUNITY
- The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
- (2015) F Amoroso et al. ONCOGENE
- Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
- (2014) E. Adinolfi et al. CANCER RESEARCH
- CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells
- (2014) Marcel Kuhny et al. Cell Communication and Signaling
- Synthesis and initial preclinical evaluation of the P2X7receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation
- (2014) Bieneke Janssen et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
- (2014) Anna Lisa Giuliani et al. PLoS One
- IL-7 Modulates In Vitro and In Vivo Human Memory T Regulatory Cell Functions through the CD39/ATP Axis
- (2013) M. Younas et al. JOURNAL OF IMMUNOLOGY
- Expression of P2X7 Receptor Increases In Vivo Tumor Growth
- (2012) E. Adinolfi et al. CANCER RESEARCH
- IL-18 associates to microvesicles shed from human macrophages by a LPS/TLR-4 independent mechanism in response to P2X receptor stimulation
- (2012) Sara Gulinelli et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7
- (2012) Fumie Hattori et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The P2X7 receptor is a key modulator of aerobic glycolysis
- (2012) F Amoroso et al. Cell Death & Disease
- The P2X7 Receptor and Pannexin-1 Are Both Required for the Promotion of Multinucleated Macrophages by the Inflammatory Cytokine GM-CSF
- (2011) I. Lemaire et al. JOURNAL OF IMMUNOLOGY
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- NTPDase1 governs P2X7-dependent functions in murine macrophages
- (2010) Sébastien A. Lévesque et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2
- (2010) Silvia Piconese et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
- (2010) Elena Adinolfi et al. FASEB JOURNAL
- Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
- (2010) Konrad Wilhelm et al. NATURE MEDICINE
- Expression of the P2X7Receptor Increases the Ca2+Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis
- (2009) Elena Adinolfi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39
- (2009) Matthew C. Hyman et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
- (2008) Patrizia Pellegatti et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started